The Fred Hutchinson Cancer Research Center in Seattle just released results of a recent study. The researchers were looking at “chemobrain,” a type of cognitive impairment that occurs following chemotherapy treatment. The study showed that tpost-chemo cognitive impairment may be longer lasting and more severe than generally believed. This finding is important because even today, some doctors whether chemobrain is a “real” condition, or a result of the increased exhaustion and weakness brought about by chemotherapy. Research on chemobrain provides support and a better level of understanding for patients who suffer from cognitive losses after cancer treatment.
About 1/3 of breast cancer survivors report mild to severe chemobrain (also known as “chemofog.”) There is no known cure, although scientists’ understanding of the underlying mechanisms leads many to believe that brain training or cognitive therapy can help